Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

P AND L

  • FDA Approval
  • Oct. 22, 2024, 08:45 UTC
  • 42
  • 0 comments

FDA approve OMEPRAZOLE MAGNESIUM

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Oct. 22, 2024, 08:45 UTC
  • 43
  • 0 comments

FDA approve MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE

Comment Full text

ALEMBIC

  • FDA Approval
  • Oct. 22, 2024, 08:45 UTC
  • 39
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

APPCO

  • FDA Approval
  • Oct. 22, 2024, 08:45 UTC
  • 41
  • 0 comments

FDA approve LABETALOL HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Oct. 22, 2024, 08:45 UTC
  • 39
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE

Comment Full text

SQ INNOVATION, INC

  • FDA Approval
  • Oct. 21, 2024, 19:12 UTC
  • 47
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 43
  • 0 comments

FDA approve PROPAFENONE HYDROCHLORIDE

Comment Full text

UBI

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 41
  • 0 comments

FDA approve LEUPROLIDE ACETATE

Comment Full text

GRANULES

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 40
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 41
  • 0 comments

FDA approve FLUVOXAMINE MALEATE

Comment Full text
  • Previous
  • 329
  • 330
  • 331
  • 332
  • 333
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137444)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin